- Home
- GDYN vs SVRA Comparison
GDYN vs SVRA Comparison
Compare GDYN & SVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GDYN
- SVRA
- Stock Information
- Founded
- GDYN 2006
- SVRA 2007
- Country
- GDYN United States
- SVRA United States
- Employees
- GDYN N/A
- SVRA N/A
- Industry
- GDYN Computer Software: Prepackaged Software
- SVRA Biotechnology: Pharmaceutical Preparations
- Sector
- GDYN Technology
- SVRA Health Care
- Exchange
- GDYN Nasdaq
- SVRA Nasdaq
- Market Cap
- GDYN 652.8M
- SVRA 527.2M
- IPO Year
- GDYN N/A
- SVRA N/A
- Fundamental
- Price
- GDYN $8.33
- SVRA $3.42
- Analyst Decision
- GDYN Strong Buy
- SVRA Buy
- Analyst Count
- GDYN 5
- SVRA 8
- Target Price
- GDYN $14.80
- SVRA $6.63
- AVG Volume (30 Days)
- GDYN 1.3M
- SVRA 1.1M
- Earning Date
- GDYN 10-30-2025
- SVRA 11-11-2025
- Dividend Yield
- GDYN N/A
- SVRA N/A
- EPS Growth
- GDYN N/A
- SVRA N/A
- EPS
- GDYN 0.19
- SVRA N/A
- Revenue
- GDYN $389,227,000.00
- SVRA N/A
- Revenue This Year
- GDYN $20.78
- SVRA N/A
- Revenue Next Year
- GDYN $10.71
- SVRA N/A
- P/E Ratio
- GDYN $42.93
- SVRA N/A
- Revenue Growth
- GDYN 22.27
- SVRA N/A
- 52 Week Low
- GDYN $7.37
- SVRA $1.89
- 52 Week High
- GDYN $25.50
- SVRA $4.30
- Technical
- Relative Strength Index (RSI)
- GDYN 52.29
- SVRA 51.37
- Support Level
- GDYN $7.98
- SVRA $3.34
- Resistance Level
- GDYN $8.64
- SVRA $3.53
- Average True Range (ATR)
- GDYN 0.37
- SVRA 0.12
- MACD
- GDYN 0.09
- SVRA -0.04
- Stochastic Oscillator
- GDYN 67.90
- SVRA 22.95
About GDYN Grid Dynamics Holdings Inc.
Grid Dynamics Holdings Inc is a provider of technology consulting, platform and product engineering, and advanced analytics services. The company delivers tailored solutions in several industry verticals like Tech, Media and Telecom, Retail, Finance and Consumer Packaged goods (CPG)/manufacturing. The company derives maximum revenue from Retails. Geographically company earns revenue from North America, Europe and other regions.
About SVRA Savara Inc.
Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.